• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清素转运体机制及变构位点作用的阐明。

Illumination of serotonin transporter mechanism and role of the allosteric site.

作者信息

Yang Dongxue, Gouaux Eric

机构信息

Vollum Institute, Oregon Health and Science University, Portland, OR 97239, USA.

Howard Hughes Medical Institute, Oregon Health and Science University, Portland, OR 97239, USA.

出版信息

Sci Adv. 2021 Dec 3;7(49):eabl3857. doi: 10.1126/sciadv.abl3857. Epub 2021 Dec 1.

DOI:10.1126/sciadv.abl3857
PMID:34851672
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8635421/
Abstract

The serotonin transporter (SERT) terminates serotonin signaling by using sodium and chloride gradients to drive reuptake of serotonin into presynaptic neurons and is the target of widely used medications to treat neuropsychiatric disorders. Despite decades of study, the molecular mechanism of serotonin transport, the coupling to ion gradients, and the role of the allosteric site have remained elusive. Here, we present cryo–electron microscopy structures of SERT in serotonin-bound and serotonin-free states, in the presence of sodium or potassium, resolving all fundamental states of the transport cycle. From the SERT-serotonin complex, we localize the substrate-bound allosteric site, formed by an aromatic pocket positioned in the scaffold domain in the extracellular vestibule, connected to the central site via a short tunnel. Together with elucidation of multiple apo state conformations, we provide previously unseen structural understanding of allosteric modulation, demonstrating how SERT binds serotonin from synaptic volumes and promotes unbinding into the presynaptic neurons.

摘要

血清素转运体(SERT)通过利用钠和氯梯度驱动血清素重新摄取到突触前神经元中来终止血清素信号传导,并且是广泛用于治疗神经精神疾病药物的靶点。尽管经过数十年的研究,血清素转运的分子机制、与离子梯度的偶联以及变构位点的作用仍然难以捉摸。在这里,我们展示了在存在钠或钾的情况下,血清素结合状态和无血清素状态下SERT的冷冻电子显微镜结构,解析了转运循环的所有基本状态。从SERT-血清素复合物中,我们定位了由位于细胞外前庭支架结构域中的芳香口袋形成的底物结合变构位点,该口袋通过一条短通道与中央位点相连。结合对多种无配体状态构象的阐明,我们提供了以前未见的变构调节结构理解,展示了SERT如何从突触间隙结合血清素并促进其释放到突触前神经元中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57fe/8635421/8a93aceddb41/sciadv.abl3857-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57fe/8635421/7fedc3c767f6/sciadv.abl3857-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57fe/8635421/f852cf323965/sciadv.abl3857-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57fe/8635421/7ba5a381823f/sciadv.abl3857-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57fe/8635421/4f71cb42c041/sciadv.abl3857-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57fe/8635421/8a93aceddb41/sciadv.abl3857-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57fe/8635421/7fedc3c767f6/sciadv.abl3857-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57fe/8635421/f852cf323965/sciadv.abl3857-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57fe/8635421/7ba5a381823f/sciadv.abl3857-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57fe/8635421/4f71cb42c041/sciadv.abl3857-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57fe/8635421/8a93aceddb41/sciadv.abl3857-f5.jpg

相似文献

1
Illumination of serotonin transporter mechanism and role of the allosteric site.血清素转运体机制及变构位点作用的阐明。
Sci Adv. 2021 Dec 3;7(49):eabl3857. doi: 10.1126/sciadv.abl3857. Epub 2021 Dec 1.
2
Multi-state Model-Based Identification of Cryptic Allosteric Sites on Human Serotonin Transporter.基于多态模型的人血清素转运体隐匿变构部位的鉴定。
ACS Chem Neurosci. 2023 May 3;14(9):1686-1694. doi: 10.1021/acschemneuro.3c00155. Epub 2023 Apr 17.
3
X-ray structures and mechanism of the human serotonin transporter.人类血清素转运体的X射线结构及作用机制
Nature. 2016 Apr 21;532(7599):334-9. doi: 10.1038/nature17629. Epub 2016 Apr 6.
4
The mechanism of a high-affinity allosteric inhibitor of the serotonin transporter.血清素转运体的高亲和力别构抑制剂的作用机制。
Nat Commun. 2020 Mar 20;11(1):1491. doi: 10.1038/s41467-020-15292-y.
5
Serotonin transporter-ibogaine complexes illuminate mechanisms of inhibition and transport.5-羟色胺转运体-伊博格碱复合物阐明了抑制和转运的机制。
Nature. 2019 May;569(7754):141-145. doi: 10.1038/s41586-019-1135-1. Epub 2019 Apr 24.
6
Identification of an allosteric modulator of the serotonin transporter with novel mechanism of action.鉴定具有新型作用机制的 5-羟色胺转运体别构调节剂。
Neuropharmacology. 2013 Sep;72:282-90. doi: 10.1016/j.neuropharm.2013.04.026. Epub 2013 Apr 28.
7
Allosteric modulation of serotonin and dopamine transporters: New insights from computations and experiments.血清素和多巴胺转运体的变构调节:来自计算和实验的新见解。
Curr Res Physiol. 2024 Mar 15;7:100125. doi: 10.1016/j.crphys.2024.100125. eCollection 2024.
8
Dynamic extracellular vestibule of human SERT: Unveiling druggable potential with high-affinity allosteric inhibitors.人源 SERT 的动态细胞外前庭:利用高亲和力变构抑制剂揭示可成药性。
Proc Natl Acad Sci U S A. 2023 Oct 10;120(41):e2304089120. doi: 10.1073/pnas.2304089120. Epub 2023 Oct 4.
9
Steric hindrance mutagenesis in the conserved extracellular vestibule impedes allosteric binding of antidepressants to the serotonin transporter.构象位阻诱变作用于保守的细胞外前庭,阻碍抗抑郁药与 5-羟色胺转运体的变构结合。
J Biol Chem. 2012 Nov 16;287(47):39316-26. doi: 10.1074/jbc.M112.371765. Epub 2012 Sep 24.
10
Structures and membrane interactions of native serotonin transporter in complexes with psychostimulants.天然血清素转运体与精神兴奋剂复合物的结构和膜相互作用。
Proc Natl Acad Sci U S A. 2023 Jul 18;120(29):e2304602120. doi: 10.1073/pnas.2304602120. Epub 2023 Jul 12.

引用本文的文献

1
Revisiting the Role of Serotonin in Attention-Deficit Hyperactivity Disorder: New Insights from Preclinical and Clinical Studies.重新审视血清素在注意力缺陷多动障碍中的作用:临床前和临床研究的新见解
Clin Drug Investig. 2025 Sep 3. doi: 10.1007/s40261-025-01473-4.
2
Cell membrane cholesterol affects serotonin transporter efflux due to altered transporter oligomerization.细胞膜胆固醇由于转运体寡聚化改变而影响5-羟色胺转运体流出。
Mol Psychiatry. 2025 Sep 2. doi: 10.1038/s41380-025-03201-y.
3
Mung Bean Starch-Derived Fermented Liquid Alleviates Constipation via 5-HT Modulation and Gut Microbiota Regulation: An In Vivo Study.

本文引用的文献

1
The antidepressant drug vilazodone is an allosteric inhibitor of the serotonin transporter.抗抑郁药维拉佐酮是一种 5-羟色胺转运体的变构抑制剂。
Nat Commun. 2021 Aug 20;12(1):5063. doi: 10.1038/s41467-021-25363-3.
2
Structural insights into the inhibition of glycine reuptake.结构洞察甘氨酸再摄取抑制。
Nature. 2021 Mar;591(7851):677-681. doi: 10.1038/s41586-021-03274-z. Epub 2021 Mar 3.
3
UCSF ChimeraX: Structure visualization for researchers, educators, and developers.UCSF ChimeraX:面向研究人员、教育工作者和开发者的结构可视化工具。
绿豆淀粉衍生发酵液通过5-羟色胺调节和肠道微生物群调控缓解便秘:一项体内研究
Foods. 2025 Jul 16;14(14):2483. doi: 10.3390/foods14142483.
4
The bile acid-sensitive ion channel is gated by Ca-dependent conformational changes in the transmembrane domain.胆汁酸敏感性离子通道由跨膜结构域中依赖钙的构象变化所门控。
Nat Commun. 2025 Jul 22;16(1):6746. doi: 10.1038/s41467-025-62038-9.
5
Dimerization and substrate recognition of human taurine transporter.人牛磺酸转运体的二聚化及底物识别
Nat Commun. 2025 Jul 4;16(1):6163. doi: 10.1038/s41467-025-60967-z.
6
The Role of Chloride Ions in Serotonin Transport.氯离子在5-羟色胺转运中的作用。
bioRxiv. 2025 May 20:2025.05.20.654092. doi: 10.1101/2025.05.20.654092.
7
Flunarizine as a potential repurposed drug for the serotonin transporter inhibition: an integrated approach for therapeutic development against major depressive disorder.氟桂利嗪作为一种潜在的用于抑制血清素转运体的重新利用药物:一种针对重度抑郁症进行治疗开发的综合方法。
Front Pharmacol. 2025 May 13;16:1599297. doi: 10.3389/fphar.2025.1599297. eCollection 2025.
8
Structure and transport mechanism of human riboflavin transporters.人类核黄素转运蛋白的结构与转运机制
Nat Commun. 2025 May 1;16(1):4078. doi: 10.1038/s41467-025-59255-7.
9
Molecular basis of human GABA transporter 3 inhibition.人类γ-氨基丁酸转运体3抑制的分子基础。
Nat Commun. 2025 Apr 23;16(1):3830. doi: 10.1038/s41467-025-59066-w.
10
Control of Conformational Transitions by the Conserved GXP Motif in the Fifth Transmembrane Domain of Neurotransmitter Sodium Symporters.神经递质钠同向转运体第五跨膜结构域中保守的GXP基序对构象转变的调控
Int J Mol Sci. 2025 Mar 26;26(7):3054. doi: 10.3390/ijms26073054.
Protein Sci. 2021 Jan;30(1):70-82. doi: 10.1002/pro.3943. Epub 2020 Oct 22.
4
Chemical and structural investigation of the paroxetine-human serotonin transporter complex.帕罗西汀-人血清素转运体复合物的化学和结构研究。
Elife. 2020 Jul 3;9:e56427. doi: 10.7554/eLife.56427.
5
Allosteric Modulation of Neurotransmitter Transporters as a Therapeutic Strategy.变构调节神经递质转运体作为一种治疗策略。
Trends Pharmacol Sci. 2020 Jul;41(7):446-463. doi: 10.1016/j.tips.2020.04.006. Epub 2020 May 26.
6
The mechanism of a high-affinity allosteric inhibitor of the serotonin transporter.血清素转运体的高亲和力别构抑制剂的作用机制。
Nat Commun. 2020 Mar 20;11(1):1491. doi: 10.1038/s41467-020-15292-y.
7
Quantifying secondary transport at single-molecule resolution.定量单分子分辨率下的次级转运。
Nature. 2019 Nov;575(7783):528-534. doi: 10.1038/s41586-019-1747-5. Epub 2019 Nov 13.
8
Serotonin transport in the 21st century.二十一世纪的血清素转运蛋白
J Gen Physiol. 2019 Nov 4;151(11):1248-1264. doi: 10.1085/jgp.201812066. Epub 2019 Sep 30.
9
Methods for merging data sets in electron cryo-microscopy.电子晶体学中的数据集合并方法。
Acta Crystallogr D Struct Biol. 2019 Sep 1;75(Pt 9):782-791. doi: 10.1107/S2059798319010519. Epub 2019 Aug 23.
10
Identification of a Novel Allosteric Modulator of the Human Dopamine Transporter.鉴定一种新型人类多巴胺转运体别构调节剂。
ACS Chem Neurosci. 2019 Aug 21;10(8):3718-3730. doi: 10.1021/acschemneuro.9b00262. Epub 2019 Jun 24.